LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Stocks making the biggest moves after hours: Adobe, Ulta and more

Garry Wills by Garry Wills
March 14, 2024
in Business Finance
Stocks making the biggest moves after hours: Adobe, Ulta and more
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

[ad_1]

Check out the companies making headlines in after-hours trading. Adobe — The software stock tumbled 10% on the back of weak guidance for current-quarter revenue. Despite that, Adobe beat analyst predictions on both lines in its fiscal first quarter and announced a $25 billion share buyback. Ulta — The beauty retailer slipped 5% as full-year earnings expectations came in on the low end of Wall Street’s forecast. Ulta said to anticipate between $26 and $27 per share for earnings over the entire year, a range that was largely below the $27 consensus estimate of analysts polled by LSEG. That overshadowed an otherwise strong outlook for revenue and a better-than-expected fourth quarter. Cardlytics — The advertising platform soared 37% after the company reported becoming positive on adjusted earnings before interest, taxes, depreciation and amortization in the full year for the first time since 2019. Cardlytics also offered stronger guidance for current quarter financials than Wall Street was anticipating. PagerDuty — Shares of the incident response platform dropped about 9% in the wake of weaker-than-expected earnings and revenue guidance for both the current quarter and full year. However, the company was able to beat analyst estimates on both lines in the fourth quarter. Zumiez — The specialty retailer shed 5% after providing a weak outlook for the current quarter. Zumiez guided for a loss per share of between $1.09 and $1.19, while analysts polled by FactSet anticipated a loss of just 34 cents. The company set quarterly revenue at a range of $167 million and $172 million, under the $186.3 million estimate from analysts. Smartsheet — The business software provider retreated by 7% as revenue guidance underwhelmed Wall Street. Smartsheet advised investors to expect between $257 million and $259 million in the current quarter and a range of $1.113 billion and $1.118 billion for the full year. Meanwhile, analysts polled by FactSet forecasted $262.3 million in revenue for the quarter and $1.14 billion for the year.

[ad_2]

Source link

You might also like

China exports growth in March misses estimates, imports surge most in over four years

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more

Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects

Share30Tweet19
Previous Post

Volkswagen is offering $13,000 off the 2023 ID.4 AWD Pro S Plus with new lease deal

Next Post

FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease

Garry Wills

Garry Wills

Recommended For You

China exports growth in March misses estimates, imports surge most in over four years
Business Finance

China exports growth in March misses estimates, imports surge most in over four years

April 14, 2026
Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more
Business Finance

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more

April 13, 2026
Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects
Business Finance

Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects

April 13, 2026
Morgan Stanley predicts these beaten-down Chinese stocks can rebound on easing Middle East tensions
Business Finance

Morgan Stanley predicts these beaten-down Chinese stocks can rebound on easing Middle East tensions

April 12, 2026
Next Post
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease

FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease

Related News

Ohio lawmaker introduces Bitcoin reserve bill allowing state to buy BTC

Ohio lawmaker introduces Bitcoin reserve bill allowing state to buy BTC

December 18, 2024
Trump’s crypto agenda is being threatened by his pursuit of personal profits

Trump’s crypto agenda is being threatened by his pursuit of personal profits

May 10, 2025
How to maintain efficient heat recovery ventilation in modern commercial spaces – London Business News | London Wallet

How to maintain efficient heat recovery ventilation in modern commercial spaces – London Business News | London Wallet

March 5, 2026

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?